
Sonavi Labs is a medical device and software company focused on developing AI-powered auscultation technology. Their flagship product, Feelix, is a digital stethoscope designed to assist global health workers, clinicians, and patients in detecting and managing respiratory diseases. Feelix enhances clinical workflow by providing features like amplification for hearing impairment, facilitating telemedicine, assisting with chronic disease management, enabling clinical research, and aiding in the teaching of medical students. The technology is compatible with EMR systems for instantaneous uploads and allows for trend analysis and customized parameters for patients. Sonavi Labs aims to create affordable, user-friendly, and accessible technology, addressing the global impact of respiratory diseases.

Sonavi Labs is a medical device and software company focused on developing AI-powered auscultation technology. Their flagship product, Feelix, is a digital stethoscope designed to assist global health workers, clinicians, and patients in detecting and managing respiratory diseases. Feelix enhances clinical workflow by providing features like amplification for hearing impairment, facilitating telemedicine, assisting with chronic disease management, enabling clinical research, and aiding in the teaching of medical students. The technology is compatible with EMR systems for instantaneous uploads and allows for trend analysis and customized parameters for patients. Sonavi Labs aims to create affordable, user-friendly, and accessible technology, addressing the global impact of respiratory diseases.
Product: Feelix — AI-powered respiratory auscultation devices and platform (consumer and clinical variants)
Founded: 2017
Headquarters: Baltimore, Maryland
Employees: 7
Total funding (reported): USD 4,500,000
Respiratory disease detection and management; remote monitoring and telemedicine for chronic respiratory conditions.
2017
Medical devices / Digital health
Seed round listed with participating investors including Synetro Group, Sand Hill Angels, PTX Capital, Nightingale Partners, and Gaingels.
USD 4,500,000
Last funding date reported as 2023-06-06 with total funding reported as USD 4,500,000.
“MedTech Innovator; Nightingale Partners; Sand Hill Angels; Synetro Group; PTX Capital; Gaingels”